L. Morgan Frisoli

Morgan Frisoli is an associate in the firm’s ERISA & Executive Compensation practice and assists with a wide range of compensation and benefits matters. Mr. Frisoli advises both public and private companies on tax and securities law issues in connection with equity-based compensation, employee benefits, and other types of incentive plans.

Mr. Frisoli has recently represented:

• Keryx Biopharmaceuticals, Inc. in its merger with Akebia Therapeutics, Inc., with an implied pro forma equity value of approximately $1.3 billion.
• Unum Therapeutics and Neon Therapeutics on their initial public offerings.
• KIND LLC, in assistance with equity compensation matters following its strategic partnership with Mars.
• Several private equity and venture capital firms in their acquisition and sale of portfolio companies.

Mr. Frisoli is a member of the Massachusetts and Boston Bar Associations.

Dividing Value in the Sale of Mixed Goods and Services for International Tax, The Practical Tax Lawyer, May 2017